Quality assurance management : a comprehensive overview of real-world applications for high risk specialities /
This book provides a comprehensive overview of quality assurance management, particularly in high-risk specialties within healthcare. It covers the development and implementation of quality management systems, auditing, and monitoring procedures, and regulatory inspections. The text delves into spec...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
London ; San Diego, CA :
Academic Press,
[2024]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- Quality Assurance Management
- Quality Assurance Management: A Comprehensive Overview of Real-World Applications for High Risk Specialties
- Copyright
- Contents
- List of contributors
- Author biographies
- 1
- Introduction
- 1.1 Introduction
- 1.1.1 A brief history
- 1.2 Quality assurance
- 1.3 Behavioral quality assurance
- 1.4 Quality control
- 1.5 Quality management
- 1.5.1 Quality management of clinical care
- 1.5.2 Quality in research using investigational medicinal products
- 1.5.3 Quality in research using medical devices
- 1.5.4 Quality management using software
- 1.6 System thinking
- 1.7 Conclusion
- References
- Further reading
- 2
- Building a quality management system
- 2.1 Introduction
- 2.1.1 Plan-do-check-act cycle
- 2.1.2 Quality improvement
- 2.1.3 Interpretation of outcomes from a PDSA cycle
- 2.2 Quality improvement methodologies
- 2.2.1 Bibliometric statistical methodology
- 2.2.2 Six Sigma methodology
- 2.2.3 Lean methodology
- 2.2.4 Lean Six Sigma methodology
- 2.2.5 Failure mode and effects analysis
- 2.2.6 Leadership for quality
- 2.2.7 Quality improvement and assurance training programs
- 2.3 Developing a quality management system
- References
- 3
- Audits and monitoring
- 3.1 Introduction
- 3.2 How to prevent failures with audits/monitoring visits?
- 3.2.1 Leadership
- 3.2.2 Creating a conducive culture
- 3.2.3 Adequate and appropriate resources
- 3.2.4 Review, monitoring, and evaluation
- References
- 4
- Inspections
- 4.1 Introduction
- 4.2 Key areas for regulatory inspections
- 4.3 Introduction to developing a specialist specific inspection plan and policy
- 4.3.1 How to address major and critical findings?
- 4.3.2 Important factors
- 4.3.3 Building a culture of resilience and adherence to quality assurance and management
- References.
- 5
- Quality assurance management in pain medicine
- 5.1 Introduction
- 5.2 Rationale for quality assurance in pain medicine
- 5.2.1 Pain classification and varying quality management approaches
- 5.2.1.1 Acute pain
- 5.2.1.2 Chronic pain
- 5.2.1.2.1 Case study-NHS Forth Valley
- 5.2.1.2.1 Case study-NHS Forth Valley
- 5.2.1.2.2 Neuropathic pain
- 5.2.1.2.2 Neuropathic pain
- 5.2.1.2.3 Improving quality of prescribing
- 5.2.1.2.3 Improving quality of prescribing
- 5.2.1.2.4 NHS Greater Glasgow and Clyde implemented a comprehensive whole-system approach that delivered significant benefits
- 5.2.1.2.4 NHS Greater Glasgow and Clyde implemented a comprehensive whole-system approach that delivered significant benefits
- 5.2.1.3 Cancer pain and palliative care
- 5.2.1.3.1 NHS Lanarkshire achieved noteworthy enhancements in the prescription of lidocaine
- 5.2.1.3.1 NHS Lanarkshire achieved noteworthy enhancements in the prescription of lidocaine
- 5.2.1.3.2 NHS Fife initiated efforts to enhance the interface between primary and secondary care
- 5.2.1.3.2 NHS Fife initiated efforts to enhance the interface between primary and secondary care
- 5.3 Patient-centered outcomes
- 5.4 Interventional pain management
- 5.4.1 Polypharmacy and the impact in pain care
- 5.5 Quality assurance in pain management-challenges and confounders
- 5.5.1 Quality assurance in pain management-a potential solution?
- References
- Further reading
- 6
- Quality assurance management in maternity care
- 6.1 Introduction
- 6.2 Association of quality management and clinical epidemiology
- 6.3 Governance implications on issues with maternity care
- 6.4 Advice for improvement
- 6.5 Digital technology for quality management
- References
- Further reading
- 7
- Neuropsychiatry and mental health
- 7.1 Background
- 7.2 Introduction.
- 7.2.1 Parallel developments in neuropsychiatric care: Neurology and neurosurgery
- 7.3 Neuropsychiatric disorders
- 7.3.1 Classification of neuropsychiatric disorders and proposed clinical considerations
- 7.3.1.1 Schizophrenia or other primary psychotic disorders
- 7.3.2 Categorical diagnosis and state of remission
- 7.3.3 Dimensional assessments: Clinical manifestation of primary diagnosed disorders
- 7.3.4 Symptom profile: Clinical manifestation of secondary comorbid disorders that reinforce primary disorder
- 7.3.4.1 Genetic influences in schizophrenia
- 7.3.5 Cellular/molecular in schizophrenia
- 7.3.6 Brain circuit activity in schizophrenia
- 7.4 Mood disorders: Depressive disorder
- 7.4.1 Categorical diagnosis: Disease severity, presence of psychotic symptoms, and degree of remission
- 7.4.2 Dimensional assessments: Clinical manifestation of primary diagnosed disorders
- 7.5 Symptom profile: Clinical manifestation of secondary comorbid disorders that reinforce primary disorder
- 7.5.1 Genetic influences in depressive disorder
- 7.5.2 Cellular/molecular in depressive disorder
- 7.6 Brain circuit activity in depressive disorder
- 7.6.1 Psychiatric surgery
- 7.6.1.1 Neural interphase
- 7.7 Anxiety or fear-related disorders: Generalized anxiety disorder
- 7.8 Categorical diagnosis and disease severity
- 7.8.1 Dimensional assessments: Clinical manifestation of primary diagnosed disorders
- 7.9 Symptom profile: Clinical manifestation of secondary comorbid disorders that reinforce primary disorders
- 7.9.1 Genetic influences in generalized anxiety disorder
- 7.9.2 Cellular/molecular in generalized anxiety disorder
- 7.9.2.1 Brain circuit activity in generalized anxiety disorder
- 7.10 Neurocognitive disorders: Alzheimer's disease and dementia
- 7.10.1 Categorical diagnosis and disease severity.
- 7.10.2 Dimensional assessments: Clinical manifestation of secondary comorbid disorders that reinforce primary disorders
- 7.11 Symptom profile with details of psychopathology: Clinical manifestation of secondary comorbid disorders that reinforce prim ...
- 7.11.1 Genetic influences in dementia
- 7.11.2 Cellular/molecular in dementia
- 7.11.3 Brain circuit activity in dementia
- 7.12 Quality assurance and quality control in neuropsychiatry
- 7.12.1 Importance of quality in neuropsychiatry and mental health
- 7.13 Importance of quality for neurology/neurosurgery in clinical research
- 7.13.1 Performance measures as quality control steps
- 7.14 Conceptual frameworks and practice-based applications used to optimize quality assurance in neuropsychiatric clinical care ...
- 7.15 Conceptual frameworks and practice-based applications used to optimizes quality assurance in neuropsychiatric and mental he ...
- 7.16 Translation of improved quality in real-world contexts
- 7.17 Managing quality optimization methods for neuropsychiatric populations
- 7.18 Quality optimization in investigational medical product development and deployment
- 7.19 Quality methods in medical device development and deployment
- 7.20 Quality control and assurance in digital technology development and deployment
- 7.21 Managing quality protocols for mental healthcare populations
- 7.22 Quality optimization in complex intervention development and deployment
- 7.23 Quality control and assurance procedures in the development and deployment of novel therapeutics
- 7.24 Future directions
- References
- Further reading
- 8
- Clinical and translational radiology
- 8.1 Background
- 8.1.1 Historical background
- 8.1.2 Radiation biology
- 8.1.2.1 Dose response models
- 8.1.2.2 Linear no-threshold model
- 8.1.2.3 Linear threshold-model
- 8.1.2.4 Linear quadratic model.
- 8.1.2.5 Radiation exposure
- stochastic versus nonstochastic effects
- 8.1.2.6 Radiation effects
- 8.1.3 Introduction to clinical radiology
- 8.1.3.1 End-to-end quality assurance
- 8.1.4 Translational imaging
- 8.1.4.1 In vivo imaging
- 8.1.4.2 Imaging biomarkers for drug discovery
- 8.1.4.3 Intraoperative imaging biomarkers
- 8.1.4.4 Translational cardio-oncology imaging
- 8.1.4.5 Molecular imaging
- 8.1.4.6 Artificial intelligence for optimizing translational imaging
- 8.1.5 Quality assurance management in translational imaging
- 8.1.5.1 Clinical trials
- 8.1.6 Radiological technology advancement
- 8.1.7 Quality control challenges for the workforce
- 8.2 Clinical radiology applications
- 8.3 Clinical utility and quality standards of imaging
- 8.3.1 Multifaceted nature of imaging and key steps for introduction of quality assurance model
- 8.3.2 Defining the scope of quality assurance steps in radiology and nuclear medicine
- 8.3.2.1 The reference number
- 8.4 Clinical radiology for clinical research
- 8.4.1 Efficacy research in radiology and nuclear medicine: basic concept
- 8.4.1.1 Learning objective
- 8.5 Quality assurance and organizational framework
- 8.5.1 Health authority
- 8.5.2 Clinical radiation expert, medical physics expert, and quality assurance
- 8.5.2.1 Medical physics expert
- 8.5.2.2 Clinical radiation expert
- 8.6 Artificial intelligence and quality assurance
- References
- Further reading
- 9
- Case studies
- 9.1 Resource influenced near misses-maternity
- 9.1.1 Case presentation
- 9.1.2 Learning objectives
- 9.2 Inspection preparedness
- 9.2.1 Case presentation
- 9.2.2 Learning outcomes
- 9.3 Risk mitigation
- 9.3.1 Presentation
- 9.3.2 Learning outcomes
- Further reading
- Index.